Clinical trial
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
NCT01237067
Study timeline
Study start (unknown)2011-02-07Date precision: day
Registry last updated2019-12-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ovarian Cancerunresolved
Breast Cancerunresolved
Primary Peritoneal Cancerunresolved
Fallopian Tube Cancerunresolved
Endometrial Cancerunresolved
Interventions
CarboplatinDRUG · verified · RxNorm: carboplatin
OlaparibDRUG · verified · RxNorm: olaparib
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01237067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.